Approximately 10 million Americans are affected by Age-Related Macular Degeneration (AMD) and understand how challenging and devastating this disease can be.
The Macula is located at the back of the eye, and is responsible for providing pertinent central vision to patients. When the Macula deteriorates or breaks down, patients start to loose their central vision, along with the ability to see fine details (such as threading needles, reading newspaper print and seeing signs while driving).
Although there is no cure for Age-Related Macular Degeneration, there is a treatment program and procedure available for patients with End-Stage AMD. CentraSight is a treatment program that utilizes an Implantable Miniature Telescope to improve visual acuity and quality of life for patients suffering from End-Stage AMD.
Once implanted, the miniature telescope magnifies images 2.7 times, which allows central vision images to be projected onto healthy parts of the eye. This magnification reduces the “blind spot” and allows the patient to distinguish and discern images that may have been unrecognizable prior to surgery.
The CentraSight program is made up of an entire team of eye care specialists, including low vision physicians, retina specialists, cornea surgeons and occupational therapists. As corneal specialists, Drs. David R. Hardten and Sherman W. Reeves are proud to be part of a local team of physicians offering this treatment to patients.
All potential candidates are screened by CentraSight case managers prior to setting up an evaluation. If you’d like more information on the CentraSight treatment program or would like to see if you qualify, visit www.centrasight.com or call 1-877-997-4448.
